Lifeward Ltd. (LS:A12BMB) Financings

Lifeward Ltd.

Financings

RaiseDate
Senior secured convertible notes and accompanying warrants
Tranche closed: US$5.6M raised
Use of proceeds: Accelerate commercialization of its restorative healthcare platform, expand its reimbursement-backed distribution model and advance its product portfolio
Jul 7, 2026
Strategic investment of ordinary shares, prefunded warrants, convertible notes and warrants
Announced: up to US$47M · additional warrants to acquire up to $7 million in ordinary shares of Lifeward
Buyers: Oramed (up to a 49.99% equity ownership in Lifeward)
Use of proceeds: Cash runway to profitability and selective investment in high-value innovation
Jan 13, 2026
Public offering of ordinary shares and accompanying warrants
Closed: US$2.6M raised · US$0.65 a share · Warrants at US$0.65 for 60 months · H.C. Wainwright & Co.
Dealers: H.C. Wainwright & Co. (lead)
Use of proceeds: Continuing commercial efforts, working capital and general corporate purposes
Jun 26, 2025
Registered direct offering of ordinary shares and unregistered warrants
Announced: about US$5M · US$2.75 a share · Warrants at US$2.75 for 36 months · H.C. Wainwright & Co.
Dealers: H.C. Wainwright & Co. (lead)
Use of proceeds: Continuing commercial efforts, working capital and general corporate purposes
Jan 7, 2025

Read by 6ix AI from the company's releases